DADS plays anti-apoptotic or anti-metastatic effects through inhibition of the PI3K/Akt signaling pathways in DU145 prostate cancer cells [52] and in esophageal–gastric junction OE19 cells [53]. Here, AKT1 is linked to prostate carcinoma.